Thursday, September 16, 1999
TRISTATE MARKET SPOTLIGHT
Guidant gets high marks, but declines
Stock in Guidant Corp. fell $3.061/4, or 5.3 percent, to $54.871/2 Wednesday, despite Wall Street attention.
The Indianapolis-based company was named to the “focus list” by analyst Ann Barber at Credit Suisse First Boston Inc.
Guidant makes and sells therapeutic medical devices for cardiac rhythm management, vascular intervention and cardiac and vascular surgery.
The company's products include automatic implantable cardioverter and defibrillator systems, implantable pacemaker systems, coronary stent systems and balloon dilation catheters.
Ford expanding transmission plant
Biotech biz needs shot in arm
How Cincinnati stacks up on the biotech front
Cinergy: N.Y. lawsuit just a pay-up tactic
River Front Classic not just a game
Hotel occupancy nearly tripled in summer
Economists see local, national slowdown
Low inflation not fazing Fed
INDUSTRY NOTES: REAL ESTATE
TRISTATE BUSINESS SUMMARY
TRISTATE MARKET SPOTLIGHT
